SELLAS Life Sciences Group Cost of Goods Sold (% of Quarterly Revenues) Insights

SELLAS Life Sciences Group, Inc. (SLS)

2.03 +0.02 (+1.00%) USD | NASDAQ | Dec 12, 16:00

2.05 +0.02 (+0.99%) After-Hours: 20:00

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for SLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cost of Goods Sold (% of Quarterly Revenues) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Cost of Goods Sold Definition

View Cost of Goods Sold Definition

Start Trial

Cost of Goods Sold (COGS) is the measure of direct costs related to the production of goods. Includes the cost of obtaining raw materials and direct labor costs.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

Start Trial

Geron Corp.	Upgrade
GT Biopharma, Inc.	--
ADMA Biologics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	--